BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Health > article

Hami's anti-obesity drug approved by FDA for rare pediatric disease program

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : June 26, 2020, 13:26 | Updated : June 26, 2020, 13:26
  • 트위터
  • 페이스북
  • 웨이보

[Courtesy of Hanmi Pharmaceutical]


SEOUL -- HM15136, an innovative anti-obesity drug under development by Hanmi Pharmaceutical, a major drugmaker in South Korea, has been approved by the U.S. Food and Drug Administration for a rare pediatric disease program.

HM15136, a biologic long-acting analog of glucagon, is being developed by Hanmi as a novel drug candidate to treat obesity with a once-weekly injection. The first-stage clinical trial is under way in the U.S to prove the efficacy of HM15136 for the treatment of congenital hyperinsulinism.

Congenital hyperinsulinism is a rare genetic disorder in which hypoglycemia is caused by excessive insulin secretion. Excess insulin causes low plasma sugar (hypoglycemia) or low blood sugar that can be very dangerous because the brain needs a constant source of sugar. The disease affects 1 in 25,000 to 50,000 babies.

Hanmi said in a statement that HM15136 was approved for a rare pediatric disease (RPD) program. "Through continuous research and development, we will contribute to improving the quality of life of patients around the world, including infants and children suffering from rare diseases," CEO Kwon Se-chang was quoted as saying.

A drug or biologic approved for an RPD program may qualify for a voucher that can be redeemed to receive a priority review of a subsequent marketing application for a different product.

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .New drug for neutropenia seeks FDA sanction.
    New drug for neutropenia seeks FDA sanction
  • .Hanmi partners with American biotech company to develop multiple bispecific antibodies..
    Hanmi partners with American biotech company to develop mult…
  • .Hanmi Global ties up with SK C&C to develop business platform for digital transformation.
    Hanmi Global ties up with SK C&C to develop business platfor…
  • .Hanmi Pharmaceutical unveils quick COVID-19 antigen test kit.
    Hanmi Pharmaceutical unveils quick COVID-19 antigen test kit
  • .French partner Sanofi decides to returns rights related to Hanmis diabetes drug candidate.
    French partner Sanofi decides to returns rights related to H…

Real Time Photo News

  • .BTS agency posts record earnings in 2020 on brisk online activities and album sales .

    BTS agency posts record earnings in 2020 on brisk online activities and album sales

  • .[FOCUS] BTS agency leagues with Universal Music to launch new K-pop band in US music scene.

    [FOCUS] BTS agency leagues with Universal Music to launch new K-pop band in US music scene

  • .CJ ENM aims to become major visual content producer thru partnership with Epic Games .

    CJ ENM aims to become major visual content producer thru partnership with Epic Games

  • .​Solo singer Sunmi to come back with new album Tail.

    ​Solo singer Sunmi to come back with new album 'Tail'

  • .Big Hits live-streaming joint venture gains reinforcements from Universal Music, YG.

    Big Hit's live-streaming joint venture gains reinforcements from Universal Music, YG

Latest News

more+

  • Prime Minister Chung stresses importance of 'borderless communication channel' to minimize informati…
  • State hospital succeeds in inserting wireless pacemakers into hearts of bradyarrhythmia patients
  • LG Electronics' joint venture with Canada's Magna awaits approval by shareholders in March
  • Sajo Seafood to launch raw tuna menu delivery service
  • Researchers find new roundworm species near Dokdo
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view